SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-038227
Filing Date
2023-11-09
Accepted
2023-11-09 16:07:45
Documents
14
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K advm-20231109.htm   iXBRL 8-K 24332
2 EX-99.1 exhibit991_110923pressrele.htm EX-99.1 78616
6 logo.jpg GRAPHIC 9327
  Complete submission text file 0001628280-23-038227.txt   250983

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20231109.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20231109_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20231109_pre.xml EX-101.PRE 12508
8 EXTRACTED XBRL INSTANCE DOCUMENT advm-20231109_htm.xml XML 2695
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 231392390
SIC: 2836 Biological Products, (No Diagnostic Substances)